Skin cancer in people of color is often diagnosed at advanced stages, resulting in higher morbidity and mortality rates.
Melanoma News
New under-the-skin (subcutaneous) nivolumab injection to be rolled out by the NHS
The NHS is rolling out a new formulation of nivolumab as a subcutaneous injection, which is an injection given just under the skin.
Pharmac funds and widens access to melanoma medicines
Pharmac is funding more medicines for people with skin cancer (melanoma), from 1 June 2025.
The Targeted Pulse: New Therapies for Melanoma, Myeloma, and More
The investigational new drug application for LP-184 has been cleared by the FDA.